Neutrophils are the first immune cells recruited to a site of injury or infection, where they perform many functions. Having completed their role, neutrophils must be removed from the inflammatory site, either by apoptosis and phagocytosis or by reverse migration away from the wound, for restoration of normal tissue homeostasis.
Introduction
Inflammation is a critical process that maintains normal tissue homeostasis following injury or infection, by removing potential pathogens and beginning the process of wound repair and healing. Neutrophils are the first immune cells recruited to a site of injury or infection, where they carry out a number of functions (Amulic, Cazalet, Hayes, Metzler, & Zychlinsky, 2012) . They destroy foreign pathogens, control the spread of infection and thereby minimise tissue damage. Neutrophils engulf bacteria and cell debris at the site of inflammation through phagocytosis and release antimicrobial molecules by degranulation. This, along with the release of reactive oxygen species, aids destruction of pathogens (Babior, Kipnes, & Cumvu, 1973) and permits neutrophil penetration into otherwise inaccessible tissues (Mittal, Siddiqui, Tran, Reddy, & Malik, 2014) . Having completed their role, neutrophils must be removed from the inflammatory site for successful inflammation resolution to occur. If this tightly controlled physiological process is disrupted, failure of inflammation resolution can lead to inflammatory diseases such as chronic obstructive pulmonary disease (COPD) .
There are several mechanisms by which neutrophils can be removed from sites of inflammation. Caspase-dependent neutrophil apoptosis and subsequent efferocytosis by macrophages has been shown to contribute to the successful resolution of inflammation in mouse (Cox, Crossley, & Xing, 1995) , human (Grigg, Savill, Sarraf, Haslett, & Silverman, 1991) and zebrafish (Gray et al., 2011) .
Neutrophil apoptosis is tightly coupled to uptake by macrophages to prevent tissue damage (Khanna et al., 2010) . Macrophages may either be tissue resident, or may be recruited from the circulating monocyte pool following neutrophil recruitment.
Macrophages phagocytose pathogens and apoptotic cells and contribute to inflammation resolution, tissue remodelling and regeneration (Murray & Wynn, 2012) , however their influence on inflammation resolution is incompletely defined.
More recently, it has been demonstrated that neutrophils can also undergo reverse migration away from sites of inflammation, which in some circumstances might contribute to the dissipation of the inflammatory burden and hence to inflammation resolution (Nourshargh, Renshaw, & Imhof, 2016; Robertson et al., 2014) . In the zebrafish, reverse migration is anti-inflammatory, and is suppressed by pro-inflammatory stimuli such as hypoxia (Elks et al., 2011) . Variations on this process have also been seen in mouse models (Woodfin et al., 2011) , and in human disease (Buckley et al., 2006) . Understanding the molecular mechanisms that govern neutrophil removal, either via efferocytosis or reverse migration, is essential to developing new therapeutics for inflammation resolution.
Macrophages are well known to be key mediators in determining the outcome of the inflammatory response (Li, Yan, Shi, Zhang, & Wen, 2012) . Macrophages and neutrophils secrete a range of pro-and anti-inflammatory cytokines, dependent on the local inflammatory environment. Studies in mammalian systems (McDonald, Fadok, Bratton, & Henson, 1999; Michlewska, Dransfield, Megson, & Rossi, 2009) have shown that upon uptake of apoptotic cells, macrophages regulate pro-and anti-inflammatory cytokine production (Fadok et al., 1998) . When fed with apoptotic neutrophils, LPS-stimulated human monocyte-derived macrophages downregulate key pro-inflammatory cytokines and upregulate anti-inflammatory mediators TGFβ1, PGE 2 and PAF. The lipid mediator PGE 2 is an eicosanoid produced by almost all cells in the body. It is an abundant metabolite of arachidonic acid generated via the action of cyclooxygenase (COX) enzymes. While PGE 2 is known to have pro-inflammatory properties under defined conditions (Tchetina et al., 2007) , it has also been shown to have anti-inflammatory functions (Scher & Pillinger, 2009 ). In zebrafish cancer models, inhibition of PGE 2 production led to a change in macrophage behaviour and enhanced pro-inflammatory activity (Feng, Renshaw, & Martin, 2012) , consistent with PGE 2 directing macrophages towards an anti-inflammatory phenotype (Y. Nakanishi et al., 2011) . In human peripheral blood neutrophils, PGE 2 switches lipid mediator biosynthesis from predominantly pro-inflammatory leukotriene B4 (5-lipoxygenase (5-LO)-initiated pathway) to lipoxin A4, which reduces neutrophil infiltration into exudates (Levy, Clish, Schmidt, Gronert, & Serhan, 2001) . These studies support a role for PGE 2 in influencing immune cell phenotype and led us to ask whether macrophages might drive lipid mediator class-switching as a mechanism for influencing inflammation resolution in vivo .
Using a zebrafish model of in vivo inflammation resolution, we examined the potential role of the lipid mediator PGE 2 in driving inflammation resolution. We demonstrate that macrophage uptake of apoptotic cells is necessary for successful inflammation resolution. PGE 2 is produced and acts via EP4 receptors to cause lipid mediator class switching and hence inflammation resolution.
Results

Macrophage clearance of apoptotic cells is necessary for successful resolution of neutrophilic inflammation in vivo .
Inflammation requires the presence and activity of both neutrophils and macrophages. To test whether neutrophil dynamics were influenced by the presence of macrophages, we ablated macrophages using tissue specific Nitroreductase expression and metronidazole treatment as previously described (Gray et al., 2011; Prajsnar et al., 2013) and counted GFP-expressing neutrophils at the site of injury.
Injury was performed on 3 day post fertilisation (dpf) larvae and neutrophil and macrophage numbers assessed at the time points indicated (Figure 1a ). In control larvae, neutrophil numbers peaked between 4 and 6 hours post injury (hpi), with numbers returning to basal levels by 24 hpi, demonstrating spontaneous resolution of inflammation. Macrophages were recruited to the site of injury at a lower rate, with numbers plateauing at 12 hpi and remaining high until at least 24 hpi. In metronidazole treated larvae, macrophages were not seen at the wound throughout the inflammatory time course, confirming successful ablation. Neutrophil numbers at the wound site were significantly increased at 24 hpi in macrophage-depleted larvae compared to control larvae, suggesting failed inflammation resolution (Figure 1a ,b).
This was in marked contrast to whole body neutrophil counts, which were unaltered ( Figure 1c ). This demonstrates that macrophages are necessary at the site of tissue injury for normal inflammation resolution to occur.
In many models of inflammation, including the zebrafish, apoptosis of neutrophils contributes to inflammation resolution (Fox, Leitch, Duffin, Haslett, & Rossi, 2010; Loynes et al., 2010) . It might therefore be expected that macrophage depletion would leave apoptotic neutrophils at the wound site. To test whether the persistence of apoptotic corpses explained the increase in neutrophil numbers, we ablated macrophages by treating transgenic zebrafish with metronidazole at 7 dpf, injuring the tailfin as before at 8 dpf and then fixing at 24 hpi in 4% paraformaldehyde for TUNEL staining. Older larvae were used to increase cell numbers involved in the inflammatory response, and hence the potential of seeing apoptotic events occurring.
We co-stained for endogenous peroxidase activity of neutrophils using a modification of the Tyramide Signal Amplification system (Loynes et al., 2010) . Double stained cells corresponding to apoptotic neutrophils were then counted in macrophage-depleted larvae. Although the number of neutrophils was higher in the metronidazole treated fish, the percentage of these neutrophils that were apoptotic was not different in the metronidazole treated group (Figure 1d ) suggesting that persisting apoptotic neutrophil corpses did not account for the increase in neutrophil numbers in the absence of macrophages. During analysis of these images, we did notice a striking and unexpected increase in TUNEL positive, TSA negative cells in macrophage-depleted larvae (Figure 1e ), corresponding to apoptotic cells from non-neutrophil lineages. Representative images of stained cells are shown in Figure   1f . This demonstrates that macrophages have an important role in removing apoptotic cells damaged during tissue injury and that neutrophil persistence is not due to un-cleared neutrophils. This suggested to us that the majority of neutrophils are being removed from the wound by an alternative mechanism, such as reverse migration (Nourshargh et al., 2016) . Neutrophil-macrophage interaction has been observed during the inflammatory response (Tauzin, Starnes, Becker, Lam, & Huttenlocher, 2014) and under some circumstances, this has been shown to alter neutrophil migratory behaviour in ways that could explain the observed failure of inflammation resolution in the absence of macrophages. We therefore sought to analyse neutrophil migration before and after interaction with macrophages to see whether the interaction caused neutrophils to migrate away from the wound, thereby dissipating the inflammatory burden. We tracked individual transgenically-labelled inflammatory cells, monitoring their interaction with other inflammatory cells. Neutrophils and macrophages were tracked during an inflammatory response and their x,y coordinates plotted ( Figure   2a ). Interaction between red (macrophage) and green (neutrophil) tracks was identified, and for each interaction we identified whether contact between a macrophage and neutrophil induced a significant change in behaviour of the neutrophil. Direct cell contact was defined as when membranes of both cell types could be seen to touch . Interaction with a macrophage made no significant difference in the neutrophil meandering index (Figure 2b ), suggesting that interaction did not lead to a change in migratory behaviour. Moreover, analysis of vector maps of neutrophils pre-and post-interaction with a macrophage showed no clear difference between the 2 vector maps. The vector maps show the overall direction a neutrophil takes during the analysed period ( Figure 2c ). When analysed, the percentage of reverse migrated neutrophils that did not interact with a macrophage was 71%, compared to 65% of neutrophils reverse migrating following a macrophage interaction ( Figure 2d ). There was no significant difference in reverse migration behaviour following macrophage interaction (Fisher's exact test p=0.78). Direct contact between macrophages and neutrophils is therefore not sufficient to completely explain the observed changes in neutrophil direction, suggesting an additional soluble factor may be involved. neutrophils without a macrophage interaction also reverse migrated away from the wound site. Chi-squared Fisher exact test indicted no significant difference in reverse migration with or without macrophage contact. P =0.78.
The eicosanoid PGE 2 is necessary for timely inflammation resolution .
Previous studies in vitro have shown that, following uptake of apoptotic cells, macrophages can alter both their profile of cytokine production and their phenotype, from pro-inflammatory to anti-inflammatory (Fadok et al., 1998) . It has been reported that levels of TGFβ1 and PGE 2 increase following phagocytosis of apoptotic cells,
whereas levels of cytokines such as IL-10 and TNFα fail to increase further. When PGE 2 production was blocked by indomethacin, TGFβ1 levels remained low, suggesting PGE 2 might be an upstream regulator of macrophage phenotype following uptake of apoptotic cells. We therefore sought to establish whether PGE 2 could be a potential mediator in enhancing inflammation resolution following tail injury in vivo .
Microsomal prostaglandin E synthase, Ptges, is necessary for the conversion of prostaglandin H 2 into PGE 2 (Claar, Hartert, & Peebles, 2015) . PGE 2 levels can be significantly reduced when Ptges expression is inhibited through the use of a morpholino antisense oligo (Cha et al., 2006) . We used a previously published morpholino to knockdown ptges to test the effect of reduced PGE 2 levels on neutrophil behaviour during inflammation. Reverse Transcriptase PCR demonstrated a significant reduction in correctly spliced ptges transcript at 4 dpf (Supplemental data 1). Neutrophil counts throughout the inflammatory response revealed a significant increase in neutrophil recruitment to the wound site. At the later time points, during the resolution phase, significantly more neutrophils were retained at the site of injury ( Figure 3a ). Since PGE 2 has been shown to be critical in haematopoiesis (North et al., 2007) , we looked at total neutrophil number in ptges morphants. Knockdown of ptges significantly reduced the number of neutrophils in the whole zebrafish (Figure 3b ), demonstrating the increase in neutrophil numbers seen during inflammation is not due to an overall increase in neutrophils within the zebrafish. These data demonstrate Ptges activity plays an important role in the resolution of inflammation.
PGE 2 is sufficient to drive inflammation resolution.
PGE 2 has both anti- (Fukunaga, Kohli, Bonnans, Fredenburgh, & Levy, 2005) and pro-inflammatory effects dependent on the timing of its production and concentration (Osma-Garcia, Punzón, Fresno, & Díaz-Muñoz, 2016; Tchetina et al., 2007) . To test whether PGE 2 is sufficient to drive inflammation resolution, we immersed 3 dpf transgenic zebrafish larvae in a range of PGE 2 concentrations at 8 hours after tailfin transection. Neutrophil numbers were then assessed at the wound at 12 hpi to look for accelerated inflammation resolution. Neutrophil numbers were significantly decreased in a dose-dependent manner when treated with PGE 2 , with 1 μM chosen as the optimal concentration ( Figure 3c ). Exogenous PGE 2 was able to rapidly enhance neutrophil removal from the site of injury to return neutrophil numbers to basal levels, thereby promoting successful inflammation resolution. As PGE 2 reduced neutrophil numbers at the site of injury, we tested if PGE 2 accelerated neutrophil apoptosis at the wound site. 3 dpf larvae were injured, treated with PGE 2 and fixed at 12 hpi for dual TUNEL (apoptosis) and TSA (neutrophil) staining. There was no difference in apoptotic cell numbers in larvae treated with PGE 2 compared to control (Supplemental data 2a.). This suggests that neutrophils are removed through a mechanism other than apoptosis.
Since exogenous PGE 2 could enhance inflammation resolution in our model, we investigated whether PGE 2 could rescue the persisting neutrophil phenotype observed with macrophage ablation. Zebrafish larvae with Nitroreductase-expressing macrophages and GFP expressing neutrophils were treated with metronidazole at 2 dpf, injured at 3 dpf and treated with PGE 2 at 8 hpi. Cell counts were performed at 12 and 24 hpi. PGE 2 was able to significantly reduce neutrophil numbers at the wound in metronidazole-treated larvae at 12 hpi compared to metronidazole only larvae, with means of 4.6+/-0.4 and 9.6+/-0.8 respectively (Supplemental data 2b). At 24 hpi, neutrophil numbers remained significantly reduced (Figure 3d ). These data demonstrate that PGE 2 can drive inflammation resolution in the absence of macrophages, thus correcting the resulting inflammatory phenotype. Neutrophil migration pattern, but not speed, is modulated by PGE 2 .
During inflammation resolution, neutrophils can be removed through multiple mechanisms, including neutrophil apoptosis (El Kebir & Filep, 2010) and reverse migration (Elks et al., 2011; Mathias et al., 2006) . Macrophage-depletion did not result in a detectable difference in apoptotic neutrophil numbers compared to control, due to either residual macrophage activity or the infrequency of neutrophil apoptosis in the zebrafish model. Nonetheless, PGE 2 can still reduce neutrophil numbers in these larvae. This implies that neutrophils involved in the inflammatory response are being removed from the site of injury through a mechanism other than efferocytosis.
We therefore investigated whether PGE 2 could enhance inflammation resolution by acceleration of neutrophil reverse migration in tail-transected zebrafish larvae. Using well established photoconversion protocols (Dixon, Elks, Loynes, Whyte, & Renshaw, 2012; Ellett et al., 2015) in transgenic zebrafish expressing the photoconvertable fluorophore kaede in neutrophils, we labelled neutrophils at the wound site at 4 hours after tailfin transection and observed the effects of addition of PGE 2 . Neutrophils at the wound site were tracked during the resolution phase of inflammation for 2 hours, from 10-12 hpi. Red, photoconverted neutrophils could be seen migrating away from the site of injury more readily in PGE 2 treated larvae (Figure 4 ). PGE 2 significantly increased the number of neutrophils moving away from the wound area (Figure 4d ).
These data show that PGE 2 drives inflammation resolution by enhanced reverse migration away from the injury site.
We then asked whether this enhanced migration from the wound could be due to an increased migration speed of the neutrophils or to them leaving the site of injury sooner. Neutrophil speed away from the site of injury was measured in the same reverse migration assays described above (Figure 4e ). There was no significant difference in migration speed, implying that PGE 2 may enhance release of neutrophils from their patrolling behaviour at the wound site. The timing of PGE 2 release is therefore critical to allow neutrophils to perform their role and then drive them away without compromising the inflammatory response. magnification on a TE2000U inverted microscope (Nikon).
Signalling through EP4 receptors contributes to inflammation resolution.
PGE 2 can signal through 4 prostanoid receptors: EP1, EP2, EP3 and EP4 (Kalinski, 2012) . The expression and distribution of these receptors vary between different tissues and cell types. EP4 is considered a stimulatory receptor and is expressed on human macrophages, with studies showing that blockage of EP4 signalling inhibits cytokine release by macrophages (Ikegami et al., 2001) . All 4 EP receptors are present in zebrafish, with multiple paralogues of each receptor . EP4b is the most abundant in adult zebrafish and is closest to human EP4 phylogenetically . To test whether PGE 2 could be signalling in vivo through EP receptors we used a previously published antagonist, AH23848, to inhibit EP4 receptor signalling (Jin et al., 2014) . Neutrophil counts at 24 hpi showed a significant increase in number when EP4 signalling was blocked, suggesting endogenous PGE 2 may act via this receptor. Addition of PGE 2 at standard doses did not lead to significant abrogation of this effect (Figure 5a ). These data suggest PGE 2 signals predominantly through the EP4 receptor, contributing significantly to inflammation resolution. However, it remained unclear how EP4 signalling might lead to altered neutrophil behaviour.
Lipid-mediator class switching downstream of PGE2 leads to inflammation resolution.
The metabolism of the membrane lipid arachidonic acid is a complex pathway, producing not only prostaglandins, but also other eicosanoids such as anti-inflammatory lipoxins and pro-inflammatory leukotrienes (Holtzman, 1991) .
Lipoxygenases are essential for the production of these metabolites, with various isozymes being key for particular pathways. Previous studies have shown that arachidonate 12-lipoxygenase (12-LO) or 15-lipoxygenase (15-LO) activity, in combination with arachidonate 5-lipoxygenase (5-LO), is required for the production of lipoxins (Lehmann et al., 2015) , and 5-LO activity alone forms leukotrienes (Primdahl, Tungen, Aursnes, Hansen, & Vik, 2015) . Increasing concentrations of PGE 2 inhibits 5-LO translocation from the cytoplasm to the nucleus, abrogating leukotriene synthesis (Rael & Lockey, 2011) , and skewing the balance between proand anti-inflammatory mediators towards increased lipoxin synthesis -a process termed "lipid-mediator class switching" (Levy et al., 2001) . Zebrafish have the three key lipoxygenase genes for lipid mediator synthesis: alox12 , alox5 and alox15b
genes (Adel, Heydeck, Kuhn, & Ufer, 2016; Chatzopoulou et al., 2016; Haas et al., 2011) . To assess the contribution of lipoxin production during inflammation resolution in the zebrafish, we immersed injured transgenic larvae in PD146176, a specific 15-LO inhibitor (Tobin et al., 2010) . We found that inhibiting 15-LO activity during inflammation led to a significant increase in neutrophil numbers at 24 hpi compared to control larvae (Figure 5b ), indicating persisting inflammation at the wound site.
This effect was dose dependant (Figure 5c ). Addition of exogenous PGE 2 following 15-LO inhibition, was unable to abrogate this effect, with neutrophil numbers remaining high at the wound site 24hpi (Figure 5d ), supporting a mechanism of PGE 2 acting upstream of 15-LO in this pathway.
The oxygenation of arachidonic acid by lipoxygenases can occur at varying positions along the fatty acid carbon chain (Schneider, Pratt, Porter, & Brash, 2009) , and can determine the functionality of the protein according to which carbon is oxygenated and which amino acid residue is present at specific sites. In zebrafish, LOX genes are annotated in Ensembl as alox12 and alox15b , yet the presence of phenylalanine (F) at position 353 and a bulky valine (V) in position 418 in reference to the rabbit leukocyte 12-LOX protein sequence (Berger et al., 1998 ) (associated with predominantly 15-LO activity in mammalian lipoxygenases (Borngräber, Kuban, Anton, & Kühn, 1996) ) suggests that zebrafish alox12 should function predominantly in the role of a 15-LO (Supplementary figure 3) . We therefore assessed alteration of expression of alox12 (the zebrafish putative 15-LO) by qPCR during injury-induced inflammation. There was a detectable increase in 12-lipoxygenase expression up to 6 hours after injury (Figure 5d ), suggesting that lipid-mediator class switching is occurring. This presents a possible mechanism for the induction of reverse migration through increased lipoxin production during inflammation resolution. 
LipoxinA4 drives inflammation resolution via reverse migration.
LipoxinA4 (LXA4) is an anti-inflammatory product of arachidonic acid metabolism that inhibits chemotaxis, transmigration, superoxide generation and the production of pro-inflammatory cytokines (Basil & Levy, 2016; Hamza et al., 2014) .
As we had previously shown an increase in alox12 expression during injury-induced inflammation, we wanted to determine if LXA4 plays a role in inflammation resolution in the zebrafish model. First, we added exogenous LXA4 to our injured larvae and assessed neutrophil number at 6 hpi. Our data demonstrate an anti-inflammatory effect of LXA4, acting to inhibit chemotaxis, significantly reducing neutrophil recruitment to the wound site ( Figure 6a ). If PGE 2 production following injury increases alox12 activity during inflammation resolution, and thereby increases LXA4 production, we would predict LXA4 could allow removal of neutrophils already present at the wound site due to loss of sensitivity to local wound signals. To assess this, we performed reverse migration experiments in the presence of exogenous LXA4. LXA4 caused neutrophils to move away from the wound earlier than in untreated larvae (Figure 6b ). LXA4 also did not alter neutrophil migration speed ( Figure 6c ). These data suggest that production of lipoxinA4 following lipid mediator class switching is the mechanism by which PGE 2 promotes inflammation resolution in vivo. The process is therefore tightly regulated. Neutrophils and macrophages as a population are well positioned to assess the threat to the organism and determine the duration of the inflammatory response. Once resolution is decided, neutrophils can either die at inflammatory sites by apoptosis and be cleared by macrophages (Grigg et al., 1991) or can be removed from inflammatory sites by altered migratory patterns (reverse migration (Mathias et al., 2006a) ). If this tightly controlled inflammatory process is disrupted, failure of inflammation resolution can lead to the tissue damage seen in chronic inflammatory diseases (Lawrence & Gilroy, 2007) . The molecular mechanisms controlling the decisions on duration of inflammation are complex and yet to be fully determined. Existing evidence indicates that lipid mediator secretion is likely to be important in signalling inflammation resolution (Serhan, 2010) but it is unknown which mediators regulate neutrophil removal from sites of inflammation in vivo . We have shown for the first time that the lipid mediator signalling molecule PGE 2 is essential for determining the outcome of neutrophil inflammation in response to tissue injury. Moreover, our data suggest that production of LipoxinA4 following lipid mediator class switching in immune cells is the critical mechanistic step by which macrophage PGE 2 release after uptake of apoptotic cells promotes inflammation resolution in vivo.
Previous in vitro studies have suggested that phagocytosis of apoptotic neutrophils by macrophages might contribute towards successful inflammation resolution (Bratton & Henson, 2011; Fadok et al., 1998) . Ingestion of apoptotic cells by macrophages promotes an anti-inflammatory environment, suppressing pro-inflammatory cytokine production (Fadok et al., 1998) . While mice lacking macrophages and neutrophils show healing without excessive inflammation or scar formation, in macrophage-only depleted mice, neutrophils populated the wound area, with impaired wound morphology and delayed healing (Goren et al., 2009) . We have shown that in the absence of macrophages, apoptotic bodies accumulate at the wound site, resulting in neutrophil persistence and prolonged inflammation. This demonstrates the importance of understanding macrophage-neutrophil interactions during inflammation resolution to prevent further damage to healing tissues.
Recent work has shown that reverse migration is a contributor to neutrophil removal from inflammatory sites (Elks et al., 2011; Mathias et al., 2006a; Starnes & Huttenlocher, 2012; Woodfin et al., 2011) . What we know about macrophage-neutrophil interactions during reverse migration in vivo comes from studies in the transparent zebrafish larval model, where (unlike in mammalian systems) these processes can readily be seen. It has been shown that macrophage recruitment and redox-SFK (Src family kinase) signalling plays a key role in neutrophil-mediated inflammation resolution (Tauzin et al., 2014) . These studies also suggest a direct contact mechanism between neutrophils and macrophages, which may direct neutrophil reverse migration. However, in the absence of macrophage contact, neutrophils are still able to reverse migrate, suggesting that other, unknown factors may be involved. Tracking analysis of macrophage and neutrophil contact in our model of inflammation demonstrates that direct contact is not an essential requirement for reverse migration. Furthermore, our studies support the importance of a soluble factor, the lipid mediator PGE 2 , for successful inflammation resolution.
Our data suggest that this lipid mediator is a key signalling molecule between macrophages and neutrophils during inflammation, leading to production of LXA4, enhancing neutrophil reverse migration and hence speeding inflammation resolution.
PGE 2 is known to be involved in many cellular processes, including cell proliferation, apoptosis, angiogenesis, inflammation and immune surveillance (reviewed by M. Nakanishi & Rosenberg, 2013) . The production of PGE 2 from prostaglandin synthases is essential for development of organisms past the gastrulation stage (Cha et al., 2006) and is crucial for hematopoietic stem cell homeostasis (North et al., 2007) . However, to our knowledge, PGE 2 has not been shown to be necessary for resolution of neutrophilic inflammation. We have shown by genetic and pharmacological approaches that the production of PGE 2 is essential for inflammation to resolve, and that PGE 2 is sufficient to drive neutrophil removal from wound sites. PGE 2 can promote neutrophil removal from wound sites in the absence of macrophages, implying an important connection between macrophages and the lipid mediator PGE 2 . This could prove to be a useful target for therapeutic intervention in chronic inflammatory disease.
PGE 2 acts via EP receptors present on a range of cell types, including neutrophils, macrophages, epithelial and endothelial cells. Neutrophils predominantly express EP2 and EP4 (Yamane, Sugimoto, Tanaka, & Ichikawa, 2000) , both of which, upon activation, cause an increase in cAMP levels within the cell. An increase in intracellular cAMP can "reprogram" the cell to switch from 5-LO products to the production of 15-LO products (Levy, 2001) . Our studies show PGE 2 signalling through EP4 receptors to be important in the resolution of neutrophilic inflammation and that this activity is mediated via 15-LO products, particularly the anti-inflammatory mediator LXA4.
Human PMNs in vitro dramatically increase expression of 15-LO mRNA in the presence of PGE 2 (Levy et al., 2001) . Our data from whole animals shows a non-significant trend towards increased expression of the annotated zebrafish 12-LO mRNA following tailfin injury, but this signal is difficult to detect in the noise of a whole animal inflammatory response. 12-LO, 12B-LO and 15B-LO expression using qPCR in zebrafish following amputation has previously been investigated in vivo (Chatzopoulou et al., 2016) . They found no statistical significance either in 12-LO or 15B-LO expression. The small changes in LO gene expression during inflammation, both in this study and our qPCR analysis, demonstrate the difficulties in detecting such small temporal changes in an in vivo system. Arachidonic acid metabolites are rapidly converted, hence making them very difficult to detect too. Therefore, analysis of multiple lipid mediators may be more insightful.
Human blood neutrophils exposed to PGE 2 inhibit LTB4 biosynthesis, and demonstrate reduced neutrophil migration (Turcotte et al., 2017) . Our data confirm the regulation of neutrophil migration by PGE 2 and LXA4 in an in vivo model of inflammation resolution. Neutrophils more readily migrate away from the wound site when exposed to exogenous PGE 2 or LXA4. The addition of PGE 2 after the maximum recruitment of neutrophils to the wound is able to dramatically enhance the reverse migration of neutrophils. The mechanism of this step is still unknown, but PGE 2 alteration of LO activity would fit with its known role in inhibiting neutrophil recruitment (Rossaint, Nadler, Ley, & Zarbock, 2012) . In our studies, exogenous LXA4 causes neutrophils to leave the wound sooner. LXA4 has been shown to inhibit chemokine signalling in neutrophils in vitro (Gewirtz et al., 1998) , suggesting a mechanism by which LXA4 facilitates neutrophil reverse migration from sites of inflammation.
Mathematical modelling data from in vivo neutrophil migration following zebrafish tail fin wounding suggests that neutrophil reverse migration is a phenomenon of stochastic redistribution of neutrophils in the tissues (Holmes et al., 2012) . This suggests a model whereby neutrophils are retained at wounds by a molecular "retention signal" and that decay of this signal leads to reverse migration (Nourshargh et al., 2016) . Chemokine receptor desensitisation would be strong candidates for explaining how these retention signals might be initiated and subsequently decayed.
LXA4 interference with these signals might be a potential mechanism by which PGE 2 ultimately alters neutrophil migration patterns leading to inflammation resolution.
In this context, an in vivo reporter would be useful to further elucidate the presence and activity of PGE 2 . Understanding the molecular mechanisms involved in neutrophil removal from wound sites, specifically during reverse migration, would greatly improve our understanding of inflammatory disease and provide potential strategies and targets for much needed therapeutic intervention. Genetics aquaria at the University of Sheffield.
Material and methods
Maintenance and breeding of zebrafish
Inflammation assay
Inflammation was induced in zebrafish embryos by tail transection as described previously (Renshaw, 2006) . Embryos were anesthetized at 3 or 8 days post fertilization (dpf) by immersion in 0.168 mg/mL Tricaine (Sigma-Aldrich), and tail transection was performed using a microscalpel (World Precision Instruments).
Neutrophils and macrophages were counted at the site of transection at various timepoints including 2, 4, 6, 8 and 24 hours post injury (hpi) using a fluorescent dissecting stereomicroscope (Leica).
In vivo cell-specific ablation
Metronidazole ( 
Cell tracking
To assess neutrophil migration behaviour pre-and post-interaction with a macrophage, transgenic larvae Tg(mpx:EGFP)i114 were crossed to Tg(mpeg1:mcherry caax )SH378 . 3 dpf larvae were injured and images were taken every 3 minutes between 0 -12 hpi using an Eclipse TE2000-U inverted compound fluorescence microscope (Nikon). Direct contact was defined as when cell membranes could be seen to touch. Comparisons of migration behaviour were made over a 30 minute period pre-and post-interaction.
Compound treatment of zebrafish larvae
Following tail transection at 3 dpf, zebrafish larvae were screened at 4 hpi for neutrophil recruitment. Selected larvae were immersed in 1µM PGE 2 (Sigma-Aldrich) at 8 hpi with counts performed at 12 hpi, to look for accelerated inflammation resolution and 24 hpi for correction of phenotype assays. Concentrations of PGE 2 ranged from 0.01µM to 10µM for dose response assays. The EP4 antagonist AH23848 (Cayman Chemicals) was used at a final concentration of 1µM. Fish were incubated at 2 dpf and with tail transection being performed at 3 dpf. PD146176, a 15-LOX inhibitor (Sigma), or LipoxinA4 (LXA4) (Cayman Chemicals) were injected into the Duct of Cuvier to a final concentration of 27nM at 2dpf, followed by tail transection and 6 or 24 hpi counts.
Reverse migration assay
Tail transection of Tg(mpx:gal4;UASkaede)i222 larvae was performed at 3 dpf.
Embryos were raised to 8 hpi, incubated in 1µM PGE 2 for 1 hour and mounted in 0.8% low-melting-point agarose (Sigma-Aldrich). An UltraVIEW PhotoKinesis device on an UltraVIEWVoX spinning disk confocal microscope (PerkinElmer Life and Analytical Sciences) was used to photoconvert Kaede-labelled cells at the wound site using 120 pulses of the 405 nm laser at 40% laser power. Embryos were transferred to an Eclipse TE2000-U inverted compound fluorescence microscope (Nikon), where a 1394 ORCA-ERA camera (Hamamatsu Photonics Inc) was used to capture a time-lapse series with 2.5 minute intervals for 2 hours. Tracking analysis of red fluorescing neutrophils was performed in Volocity 6 (Improvision; PerkinElmer Life and Analytical Sciences), using the intensity of fluorescence to identify individual labelled neutrophils over time. LXA4 was injected at 4 hpi at a final concentration of 27nM, neutrophils at the wound site photoconverted at 5 hpi and larvae were timelapsed between 6 and 15 hpi. Speed data were calculated using tracking timelapses where larvae were incubated in 10μM LXA4.
Morpholino studies
All morpholinos were obtained from GeneTools LLC, Philomath, OR, USA. ptges splice blocking morpholino is described by Feng et al, 2012 . 0.5 nl of 0.4mM of standard control morpholino (CoMo) or ptges morpholino were injected into embryos at the 1 cell stage previously described (Feng et al., 2012) . Injected larvae were incubated in 5 µM PGE 2 at the onset of epiboly to compensate for the PGE 2 required for normal development up to 42 hpf. PGE 2 was then withdrawn from the larvae at 48 hpf. At 3 dpf, larvae were injured and neutrophil counts performed at 4, 8 and 24 hpi.
Knockdown was assessed in the same fish at 48 hpf and 4 dpf using Reverse Transcriptase PCR, primer sequences were PTGESF1 5'-CTCGGGAGCGACATACAGTT-3' and PTGESR1
5'-AGCAGATATGCAACGCTGTG-3'. ptges splice blocking morpholino leads to deletion of exon 2 and a loss of 83 bp.
qPCR 3 dpf larvae were injured and total RNA was extracted using Trizol at various time points post injury. cDNA synthesis was performed using Superscript II (Thermo Scientific) and qPCR experiments using DyNAmo Flash SYBR green qPCR kit (Thermo Scientific) were carried out. ΔCT was calculated using elongation factor 1 alpha as a reference gene. Relative expression levels were plotted after determining ΔΔCt by normalizing to a single sample with a high ΔCT value. Primer sequences for alox12 gene were alox12F ccacggaatatcaccagatgga and alox12R
attcagagtcgttgtgggtatc.
Statistical analysis
Data were analysed (Prism 7.0, GraphPad Software, San Diego, CA, USA) using unpaired, two-tailed t -tests for comparisons between two groups and one-way ANOVA (with appropriate post-test adjustment) for other data.
